{
  "disease_name": "MOGS-CDG",
  "orpha_code": "79330",
  "drugs": [
    {
      "name": "DEQSIGA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/700589?name=79330&mode=orpha&region=",
      "regulatory_id": "700589",
      "orpha_substance_code": "ORPHA:101997",
      "details": [
        "DEQSIGA(Tradename                        - 02/05/2025)Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101997 Primary immunodeficiency",
        "DEQSIGA(Tradename                        - 02/05/2025)",
        "(Tradename                        - 02/05/2025)",
        "Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101997 Primary immunodeficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/700586?name=79330&mode=orpha&region=&status=all",
          "text": "DEQSIGA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3002",
          "text": "ORPHA:3002 Immune thrombocytopenia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2331",
          "text": "ORPHA:2331 Kawasaki disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2103",
          "text": "ORPHA:2103 Guillain-Barré syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2932",
          "text": "ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/641",
          "text": "ORPHA:641 Multifocal motor neuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101997",
          "text": "ORPHA:101997 Primary immunodeficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/700589?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:2103 Guillain-Barré syndrome\n                                \n\n\n\n\n                                    ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy\n                                \n\n\n\n\n                                    ORPHA:641 Multifocal motor neuropathy\n                                \n\n\n\n\n                                    ORPHA:101997 Primary immunodeficiency\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "HYQVIA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/353482?name=79330&mode=orpha&region=",
      "regulatory_id": "353482",
      "orpha_substance_code": "ORPHA:101977",
      "details": [
        "HYQVIA(Tradename                        - 16/05/2013)Disease(s) concernedORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "HYQVIA(Tradename                        - 16/05/2013)",
        "(Tradename                        - 16/05/2013)",
        "Disease(s) concernedORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/353503?name=79330&mode=orpha&region=&status=all",
          "text": "HYQVIA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2932",
          "text": "ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101977",
          "text": "ORPHA:101977 Immunodeficiency predominantly affecting antibody production",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/353482?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "HIZENTRA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/353616?name=79330&mode=orpha&region=",
      "regulatory_id": "353616",
      "orpha_substance_code": "ORPHA:183660",
      "details": [
        "HIZENTRA(Tradename                        - 14/04/2011)Disease(s) concernedORPHA:101977 Immunodeficiency predominantly affecting antibody productionORPHA:183660 Severe combined immunodeficiency",
        "HIZENTRA(Tradename                        - 14/04/2011)",
        "(Tradename                        - 14/04/2011)",
        "Disease(s) concernedORPHA:101977 Immunodeficiency predominantly affecting antibody productionORPHA:183660 Severe combined immunodeficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/353563?name=79330&mode=orpha&region=&status=all",
          "text": "HIZENTRA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101977",
          "text": "ORPHA:101977 Immunodeficiency predominantly affecting antibody production",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/183660",
          "text": "ORPHA:183660 Severe combined immunodeficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/353616?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PRIVIGEN",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/211740?name=79330&mode=orpha&region=",
      "regulatory_id": "211740",
      "orpha_substance_code": "ORPHA:101977",
      "details": [
        "PRIVIGEN(Tradename                        - 25/04/2008)Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:1959 Evans syndromeORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "PRIVIGEN(Tradename                        - 25/04/2008)",
        "(Tradename                        - 25/04/2008)",
        "Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:1959 Evans syndromeORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/211737?name=79330&mode=orpha&region=&status=all",
          "text": "PRIVIGEN",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3002",
          "text": "ORPHA:3002 Immune thrombocytopenia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2331",
          "text": "ORPHA:2331 Kawasaki disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/1959",
          "text": "ORPHA:1959 Evans syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2103",
          "text": "ORPHA:2103 Guillain-Barré syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2932",
          "text": "ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/641",
          "text": "ORPHA:641 Multifocal motor neuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101977",
          "text": "ORPHA:101977 Immunodeficiency predominantly affecting antibody production",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/211740?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:1959 Evans syndrome\n                                \n\n\n\n\n                                    ORPHA:2103 Guillain-Barré syndrome\n                                \n\n\n\n\n                                    ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy\n                                \n\n\n\n\n                                    ORPHA:641 Multifocal motor neuropathy\n                                \n\n\n\n\n                                    ORPHA:101977 Immunodeficiency predominantly affecting antibody production\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "FLEBOGAMMA DIF",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/353506?name=79330&mode=orpha&region=",
      "regulatory_id": "353506",
      "orpha_substance_code": "ORPHA:101977",
      "details": [
        "FLEBOGAMMA DIF(Tradename                        - 23/07/2007)Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:1959 Evans syndromeORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "FLEBOGAMMA DIF(Tradename                        - 23/07/2007)",
        "(Tradename                        - 23/07/2007)",
        "Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:1959 Evans syndromeORPHA:2103 Guillain-Barré syndromeORPHA:2932 Chronic inflammatory demyelinating polyneuropathyORPHA:641 Multifocal motor neuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/353505?name=79330&mode=orpha&region=&status=all",
          "text": "FLEBOGAMMA DIF",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3002",
          "text": "ORPHA:3002 Immune thrombocytopenia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2331",
          "text": "ORPHA:2331 Kawasaki disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/1959",
          "text": "ORPHA:1959 Evans syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2103",
          "text": "ORPHA:2103 Guillain-Barré syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2932",
          "text": "ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/641",
          "text": "ORPHA:641 Multifocal motor neuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101977",
          "text": "ORPHA:101977 Immunodeficiency predominantly affecting antibody production",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/353506?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:1959 Evans syndrome\n                                \n\n\n\n\n                                    ORPHA:2103 Guillain-Barré syndrome\n                                \n\n\n\n\n                                    ORPHA:2932 Chronic inflammatory demyelinating polyneuropathy\n                                \n\n\n\n\n                                    ORPHA:641 Multifocal motor neuropathy\n                                \n\n\n\n\n                                    ORPHA:101977 Immunodeficiency predominantly affecting antibody production\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "KIOVIG",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/353696?name=79330&mode=orpha&region=",
      "regulatory_id": "353696",
      "orpha_substance_code": "ORPHA:101977",
      "details": [
        "KIOVIG(Tradename                        - 19/01/2006)Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:1959 Evans syndromeORPHA:2103 Guillain-Barré syndromeORPHA:641 Multifocal motor neuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "KIOVIG(Tradename                        - 19/01/2006)",
        "(Tradename                        - 19/01/2006)",
        "Disease(s) concernedORPHA:3002 Immune thrombocytopeniaORPHA:2331 Kawasaki diseaseORPHA:1959 Evans syndromeORPHA:2103 Guillain-Barré syndromeORPHA:641 Multifocal motor neuropathyORPHA:101977 Immunodeficiency predominantly affecting antibody production",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/353561?name=79330&mode=orpha&region=&status=all",
          "text": "KIOVIG",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/3002",
          "text": "ORPHA:3002 Immune thrombocytopenia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2331",
          "text": "ORPHA:2331 Kawasaki disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/1959",
          "text": "ORPHA:1959 Evans syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2103",
          "text": "ORPHA:2103 Guillain-Barré syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/641",
          "text": "ORPHA:641 Multifocal motor neuropathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101977",
          "text": "ORPHA:101977 Immunodeficiency predominantly affecting antibody production",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/353696?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:1959 Evans syndrome\n                                \n\n\n\n\n                                    ORPHA:2103 Guillain-Barré syndrome\n                                \n\n\n\n\n                                    ORPHA:641 Multifocal motor neuropathy\n                                \n\n\n\n\n                                    ORPHA:101977 Immunodeficiency predominantly affecting antibody production\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "IgA extracted from human milk",
      "substance_url": "/en/drug/substance/689525?name=79330&mode=orpha&region=&status=all",
      "substance_id": "689525",
      "regulatory_url": "/en/drug/regulatory/690029?name=79330&mode=orpha&region=",
      "regulatory_id": "690029",
      "orpha_substance_code": "ORPHA:696851",
      "details": [
        "IgA extracted from human milk(Medicinal product                        - 25/10/2024)Disease(s) concernedORPHA:696851 Common variable immunodeficiency and related disorders",
        "IgA extracted from human milk(Medicinal product                        - 25/10/2024)",
        "(Medicinal product                        - 25/10/2024)",
        "Disease(s) concernedORPHA:696851 Common variable immunodeficiency and related disorders",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689525?name=79330&mode=orpha&region=&status=all",
          "text": "IgA extracted from human milk",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/696851",
          "text": "ORPHA:696851 Common variable immunodeficiency and related disorders",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/690029?name=79330&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:01.066528",
  "run_number": 1,
  "total_drugs_found": 7,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=MOGS-CDG&orphaCode=79330&name=79330&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "MOGS-CDG",
    "orphaCode": "79330",
    "name": "79330",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}